Clinical Trial Update: Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 completed clinical trial update for a Merck hepatitis B vaccine booster (V232-058); results were posted on 2009-10-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine booster (V232-058) (Hepatitis B vaccine booster)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2009-10-12